← Leaderboards
Chanel Alford
University Of Cincinnati
$78,670
Attributed
$78,670
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.7K · FY2021–22$50K$37.5K$25K$12.5K$0
'21
'22
Funding mix
By agency
NIH$78,670 · 1
By mechanism
F31$78,670 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Tom Cunningham$3,936,118
- Patrick A Limbach$10,289,862
- Maria F. Czyzyk-Krzeska$10,036,821
- Scott M. Langevin$750,850
- John C Byrd$38,019,882
Others in their field
Other Emerging Leaders on “Adenosine”
- Danielle L Swaney · University Of California, San Francisco$4,769,065
- Theodore E Liston · Astrocyte Pharmaceuticals, Inc.$4,495,704
- Wei Lu · Van Andel Research Institute$4,058,147
- Bing Yao · Emory University$3,941,624
- Kim-Lien T Nguyen · Va Greater Los Angeles Healthcare System$3,836,883
- Rebecca Diane Levit · Emory University$3,716,694
Research focus
AdenosineApoptosisApoptoticAreaAuxotrophyBiologicalB-LymphocytesBurkitt LymphomaCancer TherapyCell DeathCell GrowthCell LineCellsC-Myc GenesCombinatorialCommunitiesCoupledCytidineDependenceDetectionDiphosphatesDisease RemissionDoseAddiction
Grant awards (2)
Developing synergistic therapeutic strategies targeting deregulated nucleotide metabolism in MYC-driven lymphomas$39,693
F31 · FY2022 · CA · contact PI
Developing synergistic therapeutic strategies targeting deregulated nucleotide metabolism in MYC-driven lymphomas$38,977
F31 · FY2021 · CA · contact PI